免疫毒素CCL25-PE38抗急性T淋巴细胞白血病实验研究  

Study of CCL25-PE38 immunotoxin in treatment of T-cell acute lymphoblastic leukemia(T-ALL)

在线阅读下载全文

作  者:刘晓蕾[1] 高磊[2] 崔娜[3] 

机构地区:[1]河北省保定市第一中心医院血液内科,河北保定071000 [2]河北省保定市第一中心医院彩超室,河北保定071000 [3]河北省保定市第一中心医院妇科,河北保定071000

出  处:《中国现代医学杂志》2016年第20期6-11,共6页China Journal of Modern Medicine

摘  要:目的探讨免疫毒素CCL25-PE38对急性T淋巴细胞白血病(T-ALL)细胞系MOLT4(天然高水平表达CCR9)的杀伤作用,以期为T-ALL的靶向治疗提供基础。方法通过流式细胞术、共聚焦显微术检测CCL25-PE38与MOLT4细胞的结合及内化,Transwell趋化小室检测其趋化能力,细胞增殖试剂WST-1检测其细胞杀伤能力,Annexin V-FITC/PI染色检测其凋亡诱导效应,建立SCID小鼠白血病细胞异种移植肿瘤(CCR9+肿瘤)模型检测CCL25-PE38的抑瘤效果。结果 WST-1检测结果显示CCL25-PE38能特异性杀伤MOLT4细胞;Annexin V-FITC/PI染色显示CCL25-PE38主要通过凋亡诱导效应引起MOLT4细胞死亡;在SCID小鼠白血病细胞异种移植瘤模型中,注入CCL25-PE38能缓解CCR9+肿瘤的生长。结论CCL25-PE38通过凋亡诱导作用引起MOLT4细胞死亡,缓解异种移植CCR9+肿瘤的生长。Objective To investigate the killing effect of CCL25-PE38 immunotoxin on MOLT4 cell line in T-cell acute lymphoblastic leukemia (T-ALL) (CCR9 natural high-level expression), and to provide the foundation of targeting treatment of T-cell acute lymphoblastic leukemia (T-ALL). Methods Flow cytometryn and confocal microscopy were used to detect the binding and internalization of CCL25-PE38 and MOLT4 cells. Transwell chemotaxis chamber method was used to detect the chemotaxis. Cell Proliferation Reagent WST and Annexin V-FITC/PI stain were used to detect killing ability of cells and the apoptosis induced effect respectively. And antitumous effect of CCI25-PE38 was detected by building the SCID leukemia cells in mice xenograft tumor (CCR9+ tumors) model. Results WST-1 test showed that CCL25-PE38 produce specific lethal effect on MOLT4 cell. Annexin V-FITC/PI stain showed that the cause of death of MOLT4 cells was induced by apoptosis of CCL25-PE38. Injection of CCL25-PE38 in SCID leukemia cells in mice xenograft tumor (CCR9+ tumors) model can retard growth speed of CCR9+ cancer. Conclusions The cause of death of MOLT4 is induced by apoptosis-inducing effect of CCL25-PE38, which can retard the growth of CCR9+ xenotransplanted tumors.

关 键 词:CCL25-PE38 急性T淋巴细胞白血病 免疫毒素 

分 类 号:R733.71[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象